Technip Energies selected by Uniper to provide the FEED of Connah’s Quay New Combined Cycle Power Plant with Carbon Capture in the UK

(Paris:TE),(Euronext Amsterdam:TE), Technip Energies (PARIS:TE) has been awarded a Front-End Engineering Design (FEED) contract for the proposed new build Combined Cycle Gas Turbine ('CCGT') power station with Carbon Capture and Storage (CCS), at Uniper's Connah's Quay site; the Connah's Quay Low Carbon Power project. The facility would connect into nearby COâ‚‚ transport and storage infrastructure […]

AI to assist nurses: New research project reveals the potential of technology in healthcare

In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services. VTT Technical Research Centre of Finland, together with its partners, is taking part in an international research project on how artificial intelligence (AI) could support the work of nurses. In addition to VTT,

Contact Levi & Korsinsky by March 10, 2025 Deadline to Join Class Action Against BioAge Labs, Inc. (BIOA)

NEW YORK, NY / ACCESSWIRE / January 23, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=124537&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Kelun-Biotech’s Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed innovative humanized monoclonal antibody (“mAb”)tagitanlimab (formerly KL-A167) used in combination with cisplatin and gemcitabine for the first-line treatment of patients with recurrent or metastatic nasopharyngeal cancer

Bybit P2P’s Third Anniversary Celebration Culminates in Rewards Bonanza

Bybit, the world's second-largest cryptocurrency exchange by trading volume, officially marks the 3rd anniversary of its P2P platform with a celebration of user achievements. The Grand Finale campaign runs through Feb. 2025, featuring a 100,000 USDT prize pool. This final reward phase caps off Bybit P2P's series of festive giveaways that began in late 2024.

DEEDIIM Sensors Leads the Precision Inspection Market with the Launch of Compact Machine Vision Sensors

DEEDIIM Sensors Co., Ltd., a specialist in surface inspection machine vision sensors, unveiled two compact models at the Suwon Production Automation Exhibition (SMATEC) this past November. These new models are designed for small, precise surface inspections and maintain the performance of previous models while being reduced to about half the size, making them ideal for

The Now Corporation (OTC:NWPN) In Conjunction With Subsidiary Green Rain Solar Inc., Launch a Visionary Video Showcasing Solar Energy Solutions

PASADENA, CA / ACCESS Newswire / January 23, 2025 / The Now Corporation (OTC PINK:NWPN) and its subsidiary, Green Rain Solar Inc., are proud to unveil an inspiring video that highlights their mission to revolutionize urban solar energy solutions. The video, available on YouTube, provides an engaging glimpse into how Green Rain Solar Inc. is

THE FIRST-EVER EIGHT-COUNTRY HOLOCAUST KNOWLEDGE AND AWARENESS INDEX SHOWS GROWING GAP IN KNOWLEDGE ABOUT THE HOLOCAUST, ESPECIALLY IN YOUNG ADULTS

The Majority Of Respondents In Almost Every Country Surveyed Feel Something Like The Holocaust Could Happen Again; A Majority Of Respondents Also Show Strong Desire For HolocaustEducation The Conference on Jewish Material Claims Against Germany (Claims Conference) today released the first-ever, eight-countryIndex on Holocaust Knowledge and Awareness, exposing a global trend in fading knowledge of

HOME SELLING PROFITS SLIDE AGAIN IN 2024 ACROSS U.S. DESPITE CONTINUED PRICE GAINS

Profit Margins for Sellers Decrease for Second Straight Year;Typical Seller Return Remains Near Record Highs, But Declines to 54 Percent;Returns Dip Even as National Median Home Price Climbs to $350,000 ATTOM, a leading curator of land,property data, andreal estate analytics, today released its Year-End 2024 U.S. Home Sales Report, which shows that home sellers made

Scroll to Top